135 related articles for article (PubMed ID: 20034979)
1. Neoplasms with schwannian differentiation express transcription factors known to regulate normal schwann cell development.
Pytel P; Karrison T; Can Gong ; Tonsgard JH; Krausz T; Montag AG
Int J Surg Pathol; 2010 Dec; 18(6):449-57. PubMed ID: 20034979
[TBL] [Abstract][Full Text] [Related]
2. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
[TBL] [Abstract][Full Text] [Related]
4. Notch and Schwann cell transformation.
Li Y; Rao PK; Wen R; Song Y; Muir D; Wallace P; van Horne SJ; Tennekoon GI; Kadesch T
Oncogene; 2004 Feb; 23(5):1146-52. PubMed ID: 14762442
[TBL] [Abstract][Full Text] [Related]
5. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
6. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.
Stonecypher MS; Byer SJ; Grizzle WE; Carroll SL
Oncogene; 2005 Aug; 24(36):5589-605. PubMed ID: 15897877
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
[TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
9. Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
Karamchandani JR; Nielsen TO; van de Rijn M; West RB
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):445-50. PubMed ID: 22495377
[TBL] [Abstract][Full Text] [Related]
10. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
[TBL] [Abstract][Full Text] [Related]
11. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
[TBL] [Abstract][Full Text] [Related]
12. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene.
Sherman L; Jacoby LB; Lampe J; Pelton P; Aguzzi A; Herrlich P; Ponta H
Cancer Res; 1997 Nov; 57(21):4889-97. PubMed ID: 9354454
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein D is down-regulated during malignant transformation of neurofibromas.
Hunter S; Weiss S; Ou CY; Jaye D; Young A; Wilcox J; Arbiser JL; Monson D; Goldblum J; Nolen JD; Varma V
Hum Pathol; 2005 Sep; 36(9):987-93. PubMed ID: 16153462
[TBL] [Abstract][Full Text] [Related]
14. Mast cell and lymphoreticular infiltrates in neurofibromas. Comparison with nerve sheath tumors.
Johnson MD; Kamso-Pratt J; Federspiel CF; Whetsell WO
Arch Pathol Lab Med; 1989 Nov; 113(11):1263-70. PubMed ID: 2479359
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
16. Malignant peripheral nerve sheath tumors and spindle cell sarcomas: an immunohistochemical analysis of multiple markers.
Giangaspero F; Fratamico FC; Ceccarelli C; Brisigotti M
Appl Pathol; 1989; 7(2):134-44. PubMed ID: 2471540
[TBL] [Abstract][Full Text] [Related]
17. Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
Shimada S; Tsuzuki T; Kuroda M; Nagasaka T; Hara K; Takahashi E; Hayakawa S; Ono K; Maeda N; Mori N; Illei PB
Pathol Int; 2007 Feb; 57(2):60-7. PubMed ID: 17300669
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
[TBL] [Abstract][Full Text] [Related]
19. Pathologic classification of peripheral nerve tumors.
Skovronsky DM; Oberholtzer JC
Neurosurg Clin N Am; 2004 Apr; 15(2):157-66. PubMed ID: 15177315
[TBL] [Abstract][Full Text] [Related]
20. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.
Gershon TR; Oppenheimer O; Chin SS; Gerald WL
Neoplasia; 2005 Jun; 7(6):575-84. PubMed ID: 16036108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
